Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.24M | 1.69M | 1.54M | 90.70K | 2.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.52M | 2.40M | 1.12M | 2.28M | 4.59M |
| Operating Income | -2.52M | -2.40M | -1.12M | -2.28M | -4.59M |
| Income Before Tax | -2.71M | -2.92M | -1.28M | -24.03M | -4.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.71M | -2.92M | -1.28M | -24.03M | -4.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.71M | -2.92M | -1.28M | -24.03M | -4.64M |
| EBIT | -2.52M | -2.40M | -1.12M | -2.28M | -4.59M |
| EBITDA | -2.50M | -2.39M | -1.10M | -2.25M | -4.57M |
| EPS Basic | -0.01 | -0.01 | 0.00 | -0.06 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | -0.06 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 423.36M | 416.38M | 411.68M | 401.67M | 401.57M |
| Average Diluted Shares Outstanding | 423.36M | 416.38M | 411.68M | 401.67M | 401.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |